Pilot study of an occupational healthcare program to assess the SARS-CoV-2 infection and immune status of employees in a large pharmaceutical company

CONCLUSIONS: Data from this pilot program suggest that LFA for antibodies may not always reliably detect current, recent or past infections; consequently, these have not been included in our upscaled occupational healthcare program. Regular testing strategies for viral RNA and antibodies directed against different SARS-CoV-2 proteins, combined with hygiene rules and a comprehensive baseline assessment, are recommended to ensure avoidance of infections at workplace as reliably as possible.PMID:33836626 | DOI:10.1080/03007995.2021.1914943

Source: Current Medical Research and Opinion - April 10, 2021 Category: Research Authors: Petra C Moroni-Zentgraf Christoph Keller Mazyar Mahmoudi Kimberley Kallsen Christoph C Eschenfelder Ralf Sigmund Hanns Walter M üller Patrick Baum Bertram Boos Michael Schneider Egbert Mundt Source Type: research